Skip to content

PAHC

Phibro Animal Health Corporation

NASDAQ · USHealthcareDrug Manufacturers - Specialty & Generic
$33.05-0.78%

Price as of Jul 20, 2026

PAHC news

Phibro Animal Health Corporation news

A server-rendered, paginated timeline of the latest available company news.

  1. Phibro Animal Health Corporation to Participate in Stifel Jaws & Paws Conference

    Phibro Animal Health Corporation to Participate in Stifel Jaws & Paws Conference Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Stifel Jaws & Paws Conference. Executive Vice President, Corporate Strategy & CEO Designate, Daniel Bendheim; Chief Operating Officer, Larry Miller; and Chief Financial Officer, Glenn David will address financial analysts and investors on Wednesday, May 27, 2026, at 9:45 AM ET at Lotte New York Palace in New York. The live

    Business Wire ·

  2. Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance

    Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its third quarter ended March 31, 2026, and its updated financial guidance for the year ending June 30, 2026. Highlights for the three months ended March 31, 2026 (compared to the three months ended March 31, 2025): * Net sales of $383.5 million, an increase of $35.7 million, or 10% * Ne

    Business Wire ·

  3. Phibro Animal Health Corporation Launches Companywide Sustainable Solutions Platform; Introduces VERRATAIN™ Verified Sustainability Solutions Through Strategic VAXA Technologies Partnership

    Phibro Animal Health Corporation Launches Companywide Sustainable Solutions Platform; Introduces VERRATAIN™ Verified Sustainability Solutions Through Strategic VAXA Technologies Partnership Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the launch of its new Sustainable Solutions Platform (SSP), a companywide initiative designed to help animal protein, dairy and petfood producers address greenhouse gas emissions through practical, science-based solutions that integrate seamless

    Business Wire ·

  4. Phibro Animal Health Corporation Announces Regulatory Framework Change in Brazil for Antimicrobials

    Phibro Animal Health Corporation Announces Regulatory Framework Change in Brazil for Antimicrobials Phibro Animal Health Corporation (Nasdaq: PAHC) today announced expected implementation of a new regulatory framework governing the use of certain antimicrobials in Brazil that have growth promotion indications. The Brazilian Ministry of Agriculture and Livestock (MAPA) published Ordinance No. 1617 on April 27, 2026, prohibiting the importation, manufacture, marketing and use of performance enha

    Business Wire ·